In the cold heart of winter in Turku, Finland, a seemingly ordinary incident paints a stark picture of a global challenge. A jogger, battling the icy conditions, suddenly slips on a sidewalk and takes a blow to the head, causing a brief loss of consciousness. At the local hospital, an MRI reveals no immediate signs of brain injury, leading to the decision to discharge the apparently "healthy" patient. However, a subsequent test by Medicortex unveils a different story. Upon analyzing biomarkers from the patient s urine and saliva, alarming levels akin to those of confirmed Traumatic Brain Injury (TBI) patients are discovered.
Regular auroras happen because of electrons in the solar gust, but the occurrence spotted recently emanate from heavier particles called protons - a remarkable discovery in more than 50 years.
Finnish influencer issued suspended sentence over marketing sbcnews.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sbcnews.co.uk Daily Mail and Mail on Sunday newspapers.
Finnish firm earns US patent for Covid drug containing ivermectin and hydroxychloroquine
The Turku company says its nasal spray delivers low, safe doses of hydroxychloroquine, ivermectin and aprotinin.
The drug would help in situations where vaccine coverage threatens to remain too low for herd immunity, the firm says.
Image: Tiina Jutila / Yle
A coronavirus drug developed by Therapeutica Borealis, a pharmaceutical firm in Turku, has been granted a patent by the United States Patent and Trademark Office (USPTO). The nasal spray contains hydroxychloroquine, among other ingredients.
Earlier in May, the company said it had received approval for a patent application, based on which it expected a final patent this month.